2seventy bio
Cambridge
About 2seventy bio
22seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies. The company combines a deep knowledge of cancer cell biology and genetics with an understanding of the immune response to cancer to advance its pipeline. It was established in Cambridge, Massachusetts in 2021.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $10K – $50K
- Total funding: $315.0M
- Funding stage: M&A
- Last round: Post-IPO Equity (Feb 2023)
- Ticker: nasdaq:TSVT
- Website: 2seventybio.com
- Phone: 617-675-7270
Industries & Categories
Biotechnology, Genetics, Health Care, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/2seventy-bio-92512 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.